Standard Contracts
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2019 • Invus Public Equities, L.P. • Pharmaceutical preparations
The undersigned agree that the statement on Schedule 13G/A with respect to the common stock, $0.001 par value per share, of ProQR Therapeutics N.V., dated as of February 12, 2019, is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
